Literature DB >> 15328146

Invasive Streptococcus pneumoniae in France: antimicrobial resistance, serotype, and molecular epidemiology findings from a monthly national study in 2000 to 2002.

Jean-Winoc Decousser1, Patrick Pina, Florent Viguier, Franc Picot, Patrice Courvalin, Pierre Allouch.   

Abstract

A study of 257 French invasive pneumococci isolated between 2000 and 2002 showed high rates of nonsusceptibility to penicillin and macrolides (50%), contrasting with a low frequency of resistance to amoxicillin or levofloxacin (<1%) and tolerance to vancomycin (0%). The genetic homogeneity of some serogroups, including serogroup 1, enhanced the risk of epidemiological changes.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15328146      PMCID： PMC514790          DOI： 10.1128/AAC.48.9.3636-3639.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  27 in total

1.  Mechanisms of macrolide resistance in clinical pneumococcal isolates in France.

Authors:  F Fitoussi; C Doit; P Geslin; N Brahimi; E Bingen
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

2.  Molecular epidemiology survey of penicillin-susceptible and -resistant Streptococcus pneumoniae recovered from patients with meningitis in France.

Authors:  C Doit; B Picard; C Loukil; P Geslin; E Bingen
Journal:  J Infect Dis       Date:  2000-05-31       Impact factor: 5.226

3.  Prevention of pneumococcal disease by vaccination: does serotype replacement matter?

Authors:  B G Spratt; B M Greenwood
Journal:  Lancet       Date:  2000-10-07       Impact factor: 79.321

4.  The molecular epidemiology of penicillin-resistant Streptococcus pneumoniae in the United States, 1994-2000.

Authors:  S S Richter; K P Heilmann; S L Coffman; H K Huynh; A B Brueggemann; M A Pfaller; G V Doern
Journal:  Clin Infect Dis       Date:  2001-12-17       Impact factor: 9.079

5.  Prospective study of prognostic factors in community-acquired bacteremic pneumococcal disease in 5 countries.

Authors:  M Kalin; A Ortqvist; M Almela; E Aufwerber; R Dwyer; B Henriques; C Jorup; I Julander; T J Marrie; M A Mufson; R Riquelme; A Thalme; A Torres; M A Woodhead
Journal:  J Infect Dis       Date:  2000-08-17       Impact factor: 5.226

6.  Dynamics of penicillin-susceptible clones in invasive pneumococcal disease.

Authors:  B Henriques Normark; M Kalin; A Ortqvist; T Akerlund; B O Liljequist; J Hedlund; S B Svenson; J Zhou; B G Spratt; S Normark; G Källenius
Journal:  J Infect Dis       Date:  2001-08-27       Impact factor: 5.226

7.  Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States: 2-year longitudinal analysis.

Authors:  D F Sahm; J A Karlowsky; L J Kelly; I A Critchley; M E Jones; C Thornsberry; Y Mauriz; J Kahn
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

8.  In-vitro antibacterial activity of levofloxacin against hospital isolates: a multicentre study.

Authors:  C J Soussy; M Cluzel; M C Ploy; M D Kitzis; C Morel; A Bryskier; P Courvalin
Journal:  J Antimicrob Chemother       Date:  1999-06       Impact factor: 5.790

9.  Clinical isolates of Streptococcus pneumoniae that exhibit tolerance of vancomycin.

Authors:  B Henriques Normark; R Novak; A Ortqvist ; G Källenius; E Tuomanen; S Normark
Journal:  Clin Infect Dis       Date:  2001-02-09       Impact factor: 9.079

10.  Isolation and characterization of vancomycin-tolerant Streptococcus pneumoniae from the cerebrospinal fluid of a patient who developed recrudescent meningitis.

Authors:  J A McCullers; B K English; R Novak
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226
View more
  10 in total

1.  Efficacy of cethromycin, a new ketolide, against Streptococcus pneumoniae susceptible or resistant to erythromycin in a murine pneumonia model.

Authors:  E Azoulay-Dupuis; J Mohler; J P Bédos; C Barau; B Fantin
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

2.  Prevalence and molecular genetics of macrolide resistance among Streptococcus pneumoniae isolates collected in Finland in 2002.

Authors:  M Rantala; S Huikko; P Huovinen; J Jalava
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

3.  New real-time PCR assay using locked nucleic acid probes to assess prevalence of ParC mutations in fluoroquinolone-susceptible Streptococcus pneumoniae isolates from France.

Authors:  Jean-Winoc Decousser; Imen Methlouthi; Patrick Pina; Anne Collignon; Pierre Allouch
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

4.  Antimicrobial susceptibility of invasive Streptococcus pneumoniae isolates in Portugal over an 11-year period.

Authors:  Ricardo Dias; Deolinda Louro; Manuela Caniça
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

5.  Vancomycin-tolerant Streptococcus pneumoniae in Korea.

Authors:  Heungsup Sung; Hee Bong Shin; Mi-Na Kim; Kyungwon Lee; Eui-Chong Kim; Wonkeun Song; Seok Hoon Jeong; Wee-Gyo Lee; Yeon-Joon Park; George M Eliopoulos
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

6.  Clonal spread of mef-positive macrolide-resistant Streptococcus pneumoniae isolates causing invasive disease in adults in Germany.

Authors:  Mark van der Linden; Adnan Al-Lahham; Stefan Haupts; Ralf René Reinert
Journal:  Antimicrob Agents Chemother       Date:  2007-02-26       Impact factor: 5.191

Review 7.  Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic options.

Authors:  Françoise Van Bambeke; René R Reinert; Peter C Appelbaum; Paul M Tulkens; Willy E Peetermans
Journal:  Drugs       Date:  2007       Impact factor: 9.546

8.  In vitro activity of daptomycin against Staphylococci isolated from bacteremia and community-onset skin and soft tissue infections in France: data from two nationwide studies.

Authors:  O Gallon; C Guillet-Caruba; B Lamy; F Laurent; F Doucet-Populaire; J-W Decousser
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-06-06       Impact factor: 3.267

9.  Nationwide study of the prevalence, characteristics, and molecular epidemiology of extended-spectrum-beta-lactamase-producing Enterobacteriaceae in France.

Authors:  Muriel Galas; Jean-Winoc Decousser; Nelly Breton; Thierry Godard; Pierre Yves Allouch; Patrick Pina
Journal:  Antimicrob Agents Chemother       Date:  2007-11-19       Impact factor: 5.191

10.  Glycopeptide resistance in gram-positive cocci: a review.

Authors:  S Sujatha; Ira Praharaj
Journal:  Interdiscip Perspect Infect Dis       Date:  2012-06-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.